For the second year running, Comdisco's annual survey of the average age of medical imaging equipment shows lengthening scanner life cycles in all modalities. The Rosemont, IL, equipment refurbisher and financing firm said the phenomenon was attributable
For the second year running, Comdisco's annual survey of the average age of medical imaging equipment shows lengthening scanner life cycles in all modalities. The Rosemont, IL, equipment refurbisher and financing firm said the phenomenon was attributable to the drop in purchasing of new capital equipment, which results in hospitals holding on to their equipment for longer periods.
MRI scanners were particularly hard hit. The average age of installed MRI systems was 4.5 years in 1995, up from 3.1 years in 1992. In addition, 70% of MRI scanners are over three years old, compared to 35% in 1992.
The average age of other modalities in 1995 versus 1992 was as follows:
Radiography/fluoroscopy equipment continues to be the most elderly modality, with the average R/F system in 1995 purchased 10.1 years ago, compared to an average age of 7.9 years in 1992. The survey indicates that 20% of R/F systems are over 15 years old.
Not surprisingly, hospitals suffering from new-scanner sticker shock are turning to refurbished equipment, Comdisco said. The company's shipments of reconditioned medical imaging equipment this year increased 17% to $28 million, and the firm is entering 1996 with a record order backlog.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.